PRESS RELEASE: Investing in local production of medicines is a priority
Friday, October 17, 2014
If the ambitious but realistic global goal of ending the AIDS epidemic by 2030 is to become a reality, HIV prevention, testing, treatment and counselling services must be scaled up rapidly. A crucial element of this is ensuring sustainable supplies of high-quality medicines in the most affected countries.
A high-level meeting held in Geneva, Switzerland, on 14 October explored how countries can improve access to medicines and develop their domestic production, with the help of public and private investment.
Organized by the United Nations Conference on Trade and Development and UNAIDS, the session was part of the World Investment Forum 2014. Entitled Investing in Access to Medicines and Local Production in Developing Countries, the session brought together government representatives, pharmaceutical companies, senior policymakers, heads of international bodies, representatives of civil society and the media.
UNAIDS Executive Director Michel Sidibé, giving the keynote address, stressed the critical role of antiretroviral medicines in the AIDS response, and the potential benefit of innovative funding. He challenged governments and the investment community to consider new approaches to working together.
- Health Care